|
EP2918166A1
|
|
TTP/MRP14 double knock out mouse model of psoriasis
|
|
EP3071217A2
|
|
Methods, peptides and antibodies for preventing, treating and diagnosing an inflammatory condition
|
|
EP2865685A1
|
|
Electrophoretic analysis of a sample using N-Lauroylsarcosine
|
|
EP2980906A1
|
|
Fluorinated carbamates as solvent for lithium-ion electrolytes
|
|
DE102014108012A1
|
|
Substituted pyrazoles and their use as conductive salt for lithium-based energy storage
|
|
DE102014106002A1
|
|
Electrode material for sodium-based electrochemical energy storage
|
|
WO2015131933A1
|
|
Method of producing graphene by exfoliation of graphite
|
|
WO2014114803A2
|
|
Parallel elemental and molecular mass spectrometry analysis with laser ablation sampling
|
|
US2015357173A1
|
|
Laser ablation atmospheric pressure ionization mass spectrometry
|
|
DE102013114233A1
|
|
Surface modification of a lithium metal electrode
|
|
EP2883953A1
|
|
An atypical naturally split intein engineered for highly efficient protein modification
|
|
EP2926132A1
|
|
Assessment of risk of hypertension and methods based thereon
|
|
DE102013111826A1
|
|
Method for producing an electrode for a lithium-ion battery
|
|
EP2903649A1
|
|
Mek inhibitors in the treatment of virus diseases
|
|
DE102013107241A1
|
|
Conducting salt for metal-air batteries
|
|
EP2818557A1
|
|
Process for the site-specific deacetylation of xanthan employing esterases
|
|
DE102013004204A1
|
|
Micro three-electrode fluid measuring cell (MDE)
|
|
DE102013003644A1
|
|
Process for producing monolithic Laval nozzles
|
